🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Catherine B. Meador

Boston Medical Center

ORCID: 0000-0001-5006-3569

Also affiliated with Harvard University, Massachusetts General Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.481Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor‐based subtype assignment in paired tumour samples from small cell lung carcinoma

Histopathology(2023)10.1111/his.15034
Top 40%
0.481DataRank
Top 40%9 citations

Catherine B. Meador, Anna B Rider, Maria Ganci, Jaimie L. Barth, Marina Kem +3 more

Papers

Driven by 7 papers — median percentile 60. Top paper: “Liquid biopsy epigenomic profiling for cancer subtyping”.

Liquid biopsy epigenomic profiling for cancer subtyping

Nature Medicine(2023)10.1038/s41591-023-02605-z
N/A
0.722DataRank · unranked
122 citations

Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian +38 more

Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0466
N/A
0.533DataRank · unranked
34 citations

Catherine B. Meador, Xintao Qiu, Ji-Heui Seo, Matthew P. Davidsohn, Hunter Savignano +20 more

Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor‐based subtype assignment in paired tumour samples from small cell lung carcinoma

Histopathology(2023)10.1111/his.15034
Top 40%
0.481DataRank
Top 40%9 citations

Catherine B. Meador, Anna B Rider, Maria Ganci, Jaimie L. Barth, Marina Kem +3 more

Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC paralogs

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.23.546278
N/A
0.292DataRank · unranked
6 citations

Luc Girard, Jun Yi Stanley Lim, Jillian F. Wise, Braeden Freitas, Di Yang +17 more

Risk of Esophagitis in Patients with Limited Stage SCLC Treated with QD or BID Chemoradiotherapy Regimens with Contralateral Esophagus Sparing

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.711
N/A
0DataRank · unranked
0 citations

Jong Min Choi, Melin J. Khandekar, Stephen H. Thomas, C. Bowes, Catherine B. Meador +2 more

Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy

Nature Immunology(2024)10.1038/s41590-024-01792-2
N/A
0DataRank · unranked
132 citations

Linda T. Nieman, Maxwell Spurrell, Vjola Jorgji, Liad Elmelech, Peter Richieri +32 more

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100534
N/A
0DataRank · unranked
13 citations

Lesli A. Kiedrowski, Rebecca S. Heist, W. Marston Linehan, Catherine B. Meador, Elizabeth Krueger +7 more